<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05618522</url>
  </required_header>
  <id_info>
    <org_study_id>Omnigen</org_study_id>
    <secondary_id>associate professor</secondary_id>
    <nct_id>NCT05618522</nct_id>
  </id_info>
  <brief_title>Omnigen in Acute Chemical Eye Injuries</brief_title>
  <acronym>Omnigen</acronym>
  <official_title>Clinical Outcomes of Low Temperature Vacuum-dehydrated Amnion Membrane (Omnigen) in Treatment of Acute Chemical Eye Injuries</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Farwaniya Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Farwaniya Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      evaluation of the role of Omnigen in acute chemical eye injuries&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      prospective interventional study included patients with different degrees of acute chemical&#xD;
      eye injuries were treated by Omnigen and followed up for one month&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 1, 2021</start_date>
  <completion_date type="Actual">September 1, 2022</completion_date>
  <primary_completion_date type="Actual">July 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>prospective</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Epithelial healing</measure>
    <time_frame>1 week</time_frame>
    <description>slit lamp examination with cobalt blue light after installing fluroscein drops</description>
  </primary_outcome>
  <primary_outcome>
    <measure>limbal ischaemia</measure>
    <time_frame>1 week</time_frame>
    <description>slit lamp examination of the clock hours of vascularity around the limbususing both Due classification and Roper Hall</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>omnigen tolerability</measure>
    <time_frame>1 week</time_frame>
    <description>questionnaire for the patients asking about discomfort sensation or the need to patch the eye</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">21</enrollment>
  <condition>Acute Chemical Eye Injuries</condition>
  <arm_group>
    <arm_group_label>the lens loaded with Omnigen</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>patients with acute chemical eye injury treated with omnigen</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>vacuum-dehydrated amnion membrane (omnigen)</intervention_name>
    <description>applying the lens loaded with Omnigen on the cornea</description>
    <arm_group_label>the lens loaded with Omnigen</arm_group_label>
    <other_name>application of amnilenz</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>the lens loaded with Omnigen</intervention_name>
    <description>the lens loaded with Omnigen</description>
    <arm_group_label>the lens loaded with Omnigen</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  acute chemical eye injury&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  absent or shallow fornices&#xD;
&#xD;
          -  symblepharon interfering with lens placement&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Farwanyia Hospital</name>
      <address>
        <city>Al Farwānīyah</city>
        <state>Farwanyia</state>
        <zip>13001</zip>
        <country>Kuwait</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Kuwait</country>
  </location_countries>
  <verification_date>November 2022</verification_date>
  <study_first_submitted>November 9, 2022</study_first_submitted>
  <study_first_submitted_qc>November 15, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 16, 2022</study_first_posted>
  <last_update_submitted>November 15, 2022</last_update_submitted>
  <last_update_submitted_qc>November 15, 2022</last_update_submitted_qc>
  <last_update_posted type="Actual">November 16, 2022</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Farwaniya Hospital</investigator_affiliation>
    <investigator_full_name>Nancy Maher</investigator_full_name>
    <investigator_title>Senior regsistrarof ophthalmology</investigator_title>
  </responsible_party>
  <keyword>amniotic membrane</keyword>
  <keyword>chemical eye injury</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Eye Injuries</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

